Emergent BioSolutions Inc. (EBS)
NYSE: EBS · Real-Time Price · USD
9.65
+0.22 (2.33%)
Oct 23, 2025, 3:17 PM EDT - Market open
Emergent BioSolutions Market Cap
Emergent BioSolutions has a market cap or net worth of $514.84 million as of October 23, 2025. Its market cap has increased by 5.78% in one year.
Market Cap
514.84M
Enterprise Value
922.04M
1-Year Change
5.78%
Ranking
Category
Stock Price
$9.65
Market Cap Chart
Since November 15, 2006, Emergent BioSolutions's market cap has increased from $320.80M to $514.84M, an increase of 60.49%. That is a compound annual growth rate of 2.53%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Oct 22, 2025 | 503.10M | -2.88% |
Dec 31, 2024 | 518.00M | 316.06% |
Dec 29, 2023 | 124.50M | -78.87% |
Dec 30, 2022 | 589.20M | -74.81% |
Dec 31, 2021 | 2.34B | -50.75% |
Dec 31, 2020 | 4.75B | 70.50% |
Dec 31, 2019 | 2.79B | -7.78% |
Dec 31, 2018 | 3.02B | 57.00% |
Dec 29, 2017 | 1.92B | 44.63% |
Dec 30, 2016 | 1.33B | -14.64% |
Dec 31, 2015 | 1.56B | 52.38% |
Dec 31, 2014 | 1.02B | 22.29% |
Dec 31, 2013 | 836.10M | 45.38% |
Dec 31, 2012 | 575.10M | -5.00% |
Dec 30, 2011 | 605.40M | -25.67% |
Dec 31, 2010 | 814.50M | 94.58% |
Dec 31, 2009 | 418.60M | -46.42% |
Dec 31, 2008 | 781.20M | 419.07% |
Dec 31, 2007 | 150.50M | -50.82% |
Dec 29, 2006 | 306.00M | -4.61% |
Nov 15, 2006 | 320.80M | - |
View and export this data all the way back to 2006. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 725.38B |
Johnson & Johnson | 463.24B |
AbbVie | 409.12B |
UnitedHealth Group | 334.18B |
AstraZeneca | 261.56B |
Novartis AG | 254.74B |
Novo Nordisk | 249.65B |
Abbott Laboratories | 223.32B |